Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Share Market News
Should you buy shares valued to over $100 each?
Share Gainers
Cochlear Limited (ASX:COH) holds its AGM: Should you invest?
Healthcare Shares
Is ResMed Inc. (CHESS) (ASX:RMD) under threat from this high growth innovator?
Value Investing
Why I'm banking on Mayne Pharma Group Ltd (ASX:MYX) shares
Share Fallers
What you need to know to survive the ASX market meltdown
Share Market News
ALL ORDINARIES finishes higher Wednesday: 8 shares you missed
Share Gainers
Why these 4 ASX shares are storming higher today
Share Gainers
Why the Cochlear Limited (ASX:COH) share price bounced higher today
Share Market News
5 things to watch on the ASX on Wednesday
⏸️ Lessons From Investing Greats
3 timeless Howard Marks quotes for successful investing
Growth Shares
3 top healthcare shares I would buy this week
Healthcare Shares
Can Opthea Ltd (ASX:OPT) be the next Cochlear Limited (ASX:COH)?
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
